John Najim
Chief Tech/Sci/R&D Officer en DYNE THERAPEUTICS, INC. .
Perfil
John Najim is currently the Chief Technical Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as an Associate Director-Manufacturing at Dyax Corp.
and as the VP-Manufacturing & Process Development at Proteon Therapeutics, Inc. from 2009 to 2019.
Mr. Najim holds an MBA from Bentley University and an undergraduate degree from Merrimack College.
Cargos activos de John Najim
| Empresas | Cargo | Inicio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2019 |
Antiguos cargos conocidos de John Najim.
| Empresas | Cargo | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2019 |
| DYAX CORP. | Corporate Officer/Principal | - |
Formación de John Najim.
| Bentley University | Masters Business Admin |
| Merrimack College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- John Najim
